ArticleFrontiers in immunology2017

Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference.

Karine Chartrand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.